Showing results (1311-1320 of 1,430) with videos related to

Sort By:
Pageof 143
Developmental Biology|October 12, 2002
SEK1/MKK4-mediated SAPK/JNK signaling participates in embryonic hepatoblast proliferation via a pathway different from NF-kappaB-induced anti-apoptosisTomomi Watanabe, Kentaro Nakagawa, Shinya Ohata, et al.
Nature|April 4, 2014
T-cell activation by transitory neo-antigens derived from distinct microbial pathwaysAlexandra J Corbett, Sidonia B G Eckle, Richard W Birkinshaw, et al.
The EMBO Journal|January 13, 2022
Hypophosphorylated pRb knock-in mice exhibit hallmarks of aging and vitamin C-preventable diabetesZhe Jiang, Huiqin Li, Stephanie A Schroer, et al.
Blood|May 1, 1996
CD34-deficient mice have reduced eosinophil accumulation after allergen exposure and show a novel crossreactive 90-kD proteinA Suzuki, D P Andrew, J A Gonzalo, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 21, 2026
CD28-driven ex vivo generation of stem-like memory CD8<sup>+</sup> T cells bypassing CD3/TCR signalingFumie Ihara, Yota Ohashi, Evey Y F Zheng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2017
Glycogen Synthase Kinase-3 Modulates Cbl-b and Constrains T Cell ActivationCharles W Tran, Samuel D Saibil, Thierry Le Bihan, et al.
The Journal of Clinical Investigation|June 24, 2006
Enhanced PIP3 signaling in POMC neurons causes KATP channel activation and leads to diet-sensitive obesityLeona Plum, Xiaosong Ma, Brigitte Hampel, et al.
Molecular Cell|March 25, 2014
Largen: a molecular regulator of mammalian cell size controlKazuo Yamamoto, Valentina Gandin, Masato Sasaki, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2016
The IDH2 R172K mutation associated with angioimmunoblastic T-cell lymphoma produces 2HG in T cells and impacts lymphoid developmentFrançois Lemonnier, Rob A Cairns, Satoshi Inoue, et al.
Science Advances|September 7, 2022
The spindle assembly checkpoint is a therapeutic vulnerability of CDK4/6 inhibitor-resistant ER<sup>+</sup> breast cancer with mitotic aberrationsIsabel Soria-Bretones, Kelsie L Thu, Jennifer Silvester, et al.
Pageof 143